Elia BOZZATO- ADDB - Multi-drug loaded nanomedicine hydrogel for the treatment of glioblastoma

Bruxelles Woluwe

October 28, 2021

Thursday October 28, 2021, 4pm, Auditoire Maisin

Elia BOZZATO

Advanced Drug Delivery and Biomaterials (ADDB)

Multi-drug loaded nanomedicine hydrogel for the treatment of glioblastoma

Director: Prof. Véronique Préat – Co-director: Dr Chiara Bastiancich

Related publications:

  • Bastiancich*, C., Bozzato*, E., et al. (2019). Drug combination using an injectable nanomedicine hydrogel for glioblastoma treatment. International journal of pharmaceutics, 559, 220-227. Published
  • Bozzato, E., et al. (2021). Nanomedicine: A Useful Tool against Glioma Stem Cells. Cancers, 13(1), 9. Published
  • Bastiancich*, C., Bozzato*, E., et al. (2021) "Does local drug delivery still hold therapeutic promise for brain cancer? A systematic review." Journal of Controlled Release. Published
  • Bozzato, E., et al. GSC and GBM cells elimination by a dual-drug loaded nanomedicine hydrogel. In preparation
  • Gazaille, C., Bozzato E., et al. NFL peptide enhances LNC-based hydrogel effect on glioblastoma cells and prolongs animal survival. In preparation

Info : veronique.preat@uclouvain.be